| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-18 15:57 Tx date 2026-09-18 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$-18,090,108
-532,062 vol $34.00 each |
0 | |
| Filed 2026-09-18 15:55 Tx date 2026-09-18 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,320
+532,062 vol $0.01 each |
532,062 | |
| Filed 2026-09-18 15:54 Tx date 2026-06-09 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-18 15:54 Tx date 2026-09-18 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-5,320.62
-532,062 vol $0.01 each |
5,023,024 | |
| Filed 2026-08-19 10:57 Tx date 2026-07-01 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+5,828 vol |
5,828 | |
| Filed 2026-08-19 10:57 Tx date 2026-06-09 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-18 10:02 Tx date 2026-06-09 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
5,555,086 | ||
| Filed 2026-06-18 10:02 Tx date 2026-06-09 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
162,063 | ||
| Filed 2026-06-18 09:55 Tx date 2026-06-09 |
$APTX
Apotex Health Corp. |
Oberman, Allan Grant
4 - Director of Issuer
Holder: Datalo Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
266,883 | ||
| Filed 2017-04-05 Tx date 2017-03-17 |
$CXR
Concordia International Corp. (formerly Concordia Healthcare Corp.) |
Oberman, Allan Grant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
56 - Grant of rights
|
$3,342,248
+1,321,047 vol $2.53 each |
2,062,887 | |
| Filed 2017-04-05 Tx date 2017-03-17 |
$CXR
Concordia International Corp. (formerly Concordia Healthcare Corp.) |
Oberman, Allan Grant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Combination of stock options and/or restricted share units
56 - Grant of rights
|
$3,342,248
+1,321,047 vol $2.53 each |
||
| Filed 2017-03-24 Tx date 2017-03-17 |
$CXR
Concordia International Corp. (formerly Concordia Healthcare Corp.) |
Oberman, Allan Grant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Combination of stock options and/or restricted share units
56 - Grant of rights
|
$3,342,248
+1,321,047 vol $2.53 each |
1,321,047 | |
| Filed 2017-03-24 Tx date 2016-10-14 |
$CXR
Concordia International Corp. (formerly Concordia Healthcare Corp.) |
Oberman, Allan Grant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Combination of stock options and/or restricted share units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-14 Tx date 2016-10-14 |
$CXR
Concordia International Corp. (formerly Concordia Healthcare Corp.) |
Oberman, Allan Grant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-14 Tx date 2016-11-11 |
$CXR
Concordia International Corp. (formerly Concordia Healthcare Corp.) |
Oberman, Allan Grant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
56 - Grant of rights
|
$2,833,828
+741,840 vol $3.82 each |
741,840 |